He; Zhen Min

Patent Applications and Registrations

Patent applications and USPTO patent grants for He; Zhen Min.The latest application filed is for "novel pyrazolopyrimidines as cyclin dependent kinase inhibitors".

Company Profile

0.11.12

He; Zhen Min - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2	2010-10-05
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,514,442 - Guzi , et al. April 7, 2	2009-04-07
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,470,695 - Guzi , et al. December 30, 2	2008-12-30
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,468,372 - Guzi , et al. December 23, 2	2008-12-23
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,309,705 - Guzi , et al. December 18, 2	2007-12-18
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ; et al.	2007-02-15
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2	2007-01-09
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060235025 - Guzi; Timothy J. ; et al.	2006-10-19
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2	2006-10-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060178371 - Guzi; Timothy J. ; et al.	2006-08-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173017 - Guzi; Timothy J. ; et al.	2006-08-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173016 - Guzi; Timothy J. ; et al.	2006-08-03
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,084,271 - Guzi , et al. August 1, 2	2006-08-01
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,078,525 - Guzi , et al. July 18, 2	2006-07-18
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,074,924 - Guzi , et al. July 11, 2	2006-07-11
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2	2006-06-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ; et al.	2004-10-21
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040116442 - Guzi, Timothy J. ; et al.	2004-06-17
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040106624 - Guzi, Timothy J. ; et al.	2004-06-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102452 - Guzi, Timothy J. ; et al.	2004-05-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102451 - Guzi, Timothy J. ; et al.	2004-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.